ZA200602831B - Dry powder inhaler - Google Patents

Dry powder inhaler Download PDF

Info

Publication number
ZA200602831B
ZA200602831B ZA200602831A ZA200602831A ZA200602831B ZA 200602831 B ZA200602831 B ZA 200602831B ZA 200602831 A ZA200602831 A ZA 200602831A ZA 200602831 A ZA200602831 A ZA 200602831A ZA 200602831 B ZA200602831 B ZA 200602831B
Authority
ZA
South Africa
Prior art keywords
inhaler
process according
pressure
powder
fumarate dihydrate
Prior art date
Application number
ZA200602831A
Other languages
English (en)
Inventor
Olsson Magnus
Trofast Eva
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ZA200602831B publication Critical patent/ZA200602831B/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B31/00—Packaging articles or materials under special atmospheric or gaseous conditions; Adding propellants to aerosol containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C71/00—After-treatment of articles without altering their shape; Apparatus therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/02—General characteristics of the apparatus characterised by a particular materials
    • A61M2205/0233—Conductive materials, e.g. antistatic coatings for spark prevention
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C2791/00—Shaping characteristics in general
    • B29C2791/004—Shaping under special conditions
    • B29C2791/006—Using vacuum
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00—Other particular articles
    • B29L2031/753—Medical equipment; Accessories therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mechanical Engineering (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
ZA200602831A 2003-10-07 2006-04-06 Dry powder inhaler ZA200602831B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0302665A SE0302665D0 (sv) 2003-10-07 2003-10-07 Novel Process

Publications (1)

Publication Number Publication Date
ZA200602831B true ZA200602831B (en) 2007-07-25

Family

ID=29398687

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200602831A ZA200602831B (en) 2003-10-07 2006-04-06 Dry powder inhaler

Country Status (15)

Country Link
US (2) US7896005B2 (enExample)
EP (1) EP1680163A1 (enExample)
JP (1) JP4589928B2 (enExample)
KR (1) KR101110444B1 (enExample)
CN (2) CN1889991B (enExample)
AU (1) AU2004280109B2 (enExample)
BR (1) BRPI0415189A (enExample)
CA (1) CA2541374C (enExample)
IL (1) IL174735A (enExample)
MX (1) MXPA06003872A (enExample)
NO (1) NO336190B1 (enExample)
NZ (1) NZ546405A (enExample)
SE (1) SE0302665D0 (enExample)
WO (1) WO2005035036A1 (enExample)
ZA (1) ZA200602831B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1015883A3 (fr) * 2004-06-08 2005-10-04 Occhio Procede et dispositif de dispersion de poudres seches.
US8524735B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
CA2739897C (en) 2008-10-07 2017-10-03 Mpex Pharmaceuticals, Inc. Aerosol fluoroquinolone formulations for improved pharmacokinetics
US8629139B2 (en) 2008-10-07 2014-01-14 Mpex Pharmaceuticals, Inc. Topical use of Levofloxacin for reducing lung inflammation
GB0912373D0 (en) 2009-07-16 2009-08-26 Innovata Biomed Ltd Improvements in or relating to dry powder inhalers
DK2473170T3 (da) 2009-09-04 2019-08-12 Horizon Orphan Llc Anvendelse af aerosoliseret levofloxacin til behandling af cystisk fibrose
GB201118188D0 (en) * 2011-10-21 2011-12-07 3M Innovative Properties Co Manufacture of medicinal aerosol canisters
US11052202B2 (en) * 2012-11-07 2021-07-06 Chiesi Farmaceutici S.P.A. Drug delivery device for the treatment of patients with respiratory diseases
CN106163595B (zh) * 2014-03-03 2020-07-24 安瑞智能(新西兰)有限公司(新西兰) 用于干粉药物递送设备的顺从性监视器
NO2709641T3 (enExample) 2014-03-10 2018-05-12
EP3340982B1 (en) 2015-08-26 2021-12-15 Achillion Pharmaceuticals, Inc. Compounds for treatment of immune and inflammatory disorders
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
CN109414441A (zh) 2016-06-27 2019-03-01 艾其林医药公司 治疗医学障碍的喹唑啉和吲哚化合物
KR102632860B1 (ko) 2017-03-01 2024-02-02 아칠리온 파르마세우티칼스 인코포레이티드 의학적 장애의 치료를 위한 아릴, 헤테로아릴, 및 헤테로사이클릭 약학적 화합물
CN108771761B (zh) * 2018-08-16 2021-12-14 上海方予健康医药科技有限公司 一种糖皮质激素与β2受体激动剂的复方干粉吸入剂的制备工艺
US20230022157A1 (en) 2018-08-20 2023-01-26 Achillion Pharmaceuticals, Inc. Pharmaceutical compounds for the treatment of complement factor d medical disorders
WO2020081723A1 (en) 2018-10-16 2020-04-23 Georgia State University Research Foundation, Inc. Carbon monoxide prodrugs for the treatment of medical disorders
CN119837855A (zh) 2019-12-19 2025-04-18 乔治亚州大学研究基金会 用于治疗细菌感染和增强抗生素的化合物
CN115362162A (zh) 2020-02-20 2022-11-18 艾其林医药公司 用于治疗补体因子d介导的障碍的杂芳基化合物
USD949321S1 (en) * 2020-05-29 2022-04-19 NuvoAir AB Housing for an add-on sensor for an inhaler
CA3193488A1 (en) 2020-09-23 2022-03-31 Jason Allan Wiles Pharmaceutical compounds for the treatment of complement mediated disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE23272T1 (de) * 1981-07-08 1986-11-15 Draco Ab Pulverinhalator.
SE9400257D0 (sv) 1994-01-27 1994-01-27 Astra Ab Spacer
SE9400570D0 (sv) 1994-02-21 1994-02-21 Astra Ab Inhalation device, inhaler and processing unit
US6390291B1 (en) * 1998-12-18 2002-05-21 Smithkline Beecham Corporation Method and package for storing a pressurized container containing a drug
US6315112B1 (en) * 1998-12-18 2001-11-13 Smithkline Beecham Corporation Method and package for storing a pressurized container containing a drug
US6119853A (en) * 1998-12-18 2000-09-19 Glaxo Wellcome Inc. Method and package for storing a pressurized container containing a drug
GB2353222B (en) * 1999-06-23 2001-09-19 Cambridge Consultants Inhalers
GB0107106D0 (en) 2001-03-21 2001-05-09 Boehringer Ingelheim Pharma Powder inhaler formulations
US20050123509A1 (en) 2001-10-19 2005-06-09 Lehrman S. R. Modulating charge density to produce improvements in the characteristics of spray-dried proteins
GB0130857D0 (en) * 2001-12-22 2002-02-06 Glaxo Group Ltd Medicament dispenser

Also Published As

Publication number Publication date
US7896005B2 (en) 2011-03-01
IL174735A0 (en) 2006-08-20
CN1889991A (zh) 2007-01-03
AU2004280109B2 (en) 2008-05-22
US20110056089A1 (en) 2011-03-10
JP2007507270A (ja) 2007-03-29
US8205611B2 (en) 2012-06-26
NO20062065L (no) 2006-06-29
CA2541374A1 (en) 2005-04-21
KR101110444B1 (ko) 2012-02-17
SE0302665D0 (sv) 2003-10-07
NO336190B1 (no) 2015-06-08
IL174735A (en) 2010-12-30
KR20060115728A (ko) 2006-11-09
NZ546405A (en) 2008-11-28
US20070107721A1 (en) 2007-05-17
AU2004280109A1 (en) 2005-04-21
WO2005035036A1 (en) 2005-04-21
EP1680163A1 (en) 2006-07-19
CN1889991B (zh) 2010-09-08
CN101856532A (zh) 2010-10-13
BRPI0415189A (pt) 2006-11-28
JP4589928B2 (ja) 2010-12-01
MXPA06003872A (es) 2006-07-03
CA2541374C (en) 2013-05-14

Similar Documents

Publication Publication Date Title
US8205611B2 (en) Dry powder inhaler
US20230364015A1 (en) Process for providing particles with reduced electrostatic charges
Newman et al. Evolution of dry powder inhaler design, formulation, and performance
EP2890437B1 (en) Aerosol inhalation device
Maggi et al. Influence of the moisture on the performance of a new dry powder inhaler
WO2008008021A1 (en) Inhalation system and delivery device for the administration of a drug in the form of dry powder.
JP2007513152A (ja) 耐湿性容器内のチオトロピウムから構成される医薬製品
Yang et al. Drug delivery performance of the mometasone furoate dry powder inhaler
UA123231C2 (uk) Комбінована терапія для хохл
JP2007507270A5 (enExample)
CN107205936A (zh) 包含至少一种通过喷雾干燥得到的增加制剂稳定性的干粉的组合物
KR20150010757A (ko) 신규한 투약량 및 제형
WO2004110404A1 (en) Combined doses of tiotropium and fluticasone
EP1691839A1 (en) Combined doses
Clark et al. The application of pulmonary inhalation technology to drug discovery
WO2025229354A1 (en) Aerosol comprising salbutamol sulfate and beclomethasone dipropionate
HK1174570B (en) Process for providing particles with reduced electrostatic charges
TW201605432A (zh) 新穎劑量及調配物